Public funding highlights

Public funding highlights

Selected developments and initiatives in 2Q19 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of Health Research (CIHR), the Agency for Science Technology and Research (A*STAR) and the Japan Agency for Medical Research and Development (AMED).

DateAgencySummaryType
Apr. 11IMIFor its June calls for proposals, IMI announced it will focus on CAR T cell development and other curative cell and gene therapies, AI for pathology, patient access to healthcare information and patient outcome data. The total budget is €45 million ($49.5

Read the full 985 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE